Eric D Perakslis, Ph.D.
Eric D Perakslis, Ph.D.
Lecturer on Biomedical Informatics, Part-time

Eric Perakslis is a research, informatics, technology and R&D leader with more than 19 years of direct experience in information technology, informatics, research, healthcare, government regulation, biotechnology and pharmaceuticals discovery and development.

He received his PhD in Chemical and Biochemical Engineering from Drexel University. Following a stint with ArQule, Inc., he joined the Johnson and Johnson companies, serving first as Director of Drug Discovery Global Information Solutions, NA  at RWJ Pharmaceutical Research and progressing to Vice President R&D Informatics at Centocor and Member of the J&J Corporate Office of Science and Technology and ultimately to Sr Vice President, CIO at J&J Pharma R&D and Head of Translational Informatics at J&J Corporate Office of Science and Development. Perakslis became CIO and Chief Scientist (Informatics) at the FDA in 2011 before moving to HMS to serve as Executive Director at the Center for Biomedical Informatics. He currently is Senior VP, R&D Informatics at Takeda Pharmaceuticals International Inc. in Cambridge, MA.

Cybersecurity in health care.
Authors: Perakslis ED.
N Engl J Med
View full abstract on Pubmed
Translational informatics in personalized medicine: an update for 2014.
Authors: Perakslis ED, Shon J.
Per Med
View full abstract on Pubmed
The global need for education on cancer health.
Authors: Perakslis ED, Quintana Y.
Stud Health Technol Inform
View full abstract on Pubmed
Translational informatics in personalized medicine.
Authors: Perakslis ED, Shon J.
Per Med
View full abstract on Pubmed
Effective knowledge management in translational medicine.
Authors: Szalma S, Koka V, Khasanova T, Perakslis ED.
J Transl Med
View full abstract on Pubmed
How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
Authors: Perakslis ED, Van Dam J, Szalma S.
Clin Pharmacol Ther
View full abstract on Pubmed
Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids.
Authors: Perakslis E, Tuesca A, Lowman A.
J Biomater Sci Polym Ed
View full abstract on Pubmed